search buttonmobile navigation expand button

Back to Search Results

World’s first naturally-dissolving stent available through McLaren Clarkston

Published on Monday, January 16, 2017

Abbott Absorb bioresorbable stentCLARKSTON, Mich.—The Abbott Absorb™ bioresorbable stent, an FDA-approved naturally-dissolving heart stent, is now available to McLaren Clarkston patients through the health system-owned McLaren Cardiovascular Institute. The first medical device of its kind, the Absorb stent has produced enhanced clinical outcomes in patients without the concern of a permanent implant for those suffering from coronary artery disease.

Procedures through McLaren Clarkston are performed by McLaren Cardiovascular Institute interventional cardiologists at Mount Clemens-based McLaren Macomb. Patients are provided transportation while their families are met by a patient experience representative and escorted to their loved one.

A clogging of the arteries, restricting blood flow to the heart, coronary artery disease (CAD) affects more than 15 million Americans and remains a leading causes of death worldwide. The Absorb stent is a major advancement in the treatment of CAD.

“The approval and launch of this device represents a significant advancement in our ability to treat chronic heart disease,” said Dr. Timothy Logan, an interventional cardiologist with the McLaren Cardiovascular Institute. “Dissolved entirely after three years, patients and physicians alike don’t have to commit themselves to a permanent implant, which leads to reduced anxiety while also maintaining the standard of care.”

Traditionally, stents were permanent, metal implants. The Absorb stent is made of a naturally-dissolving material similar to dissolving sutures, disappearing after three years. After having completed its task of keeping a clogged artery open, the stent leaves behind only four markers for future reference of its placement.

During extensive clinical trials, the Absorb stent maintained the standard of care established by the leading metallic stent. However, no metal will allow the stented artery to naturally pulse and flex as the demands of the heart change with the increase and decrease of daily, physical activity.

McLaren Cardiovascular Institute interventional cardiologists underwent extensive training to ensure optimal clinical outcomes.

To learn more about the cardiac care offered at the McLaren Cardiovascular Institute or to schedule an appointment with a cardiologist, visit

About McLaren Oakland
McLaren Oakland is a 328-bed medical center that provides primary and specialty healthcare services to the greater Pontiac and Oakland County community. Founded in 1953, McLaren Oakland has grown to a comprehensive medical community that includes outpatient facilities in Clarkston and Oxford, as well as an inpatient hospital providing a range of clinical services including emergency and trauma care, cardiology, cancer services, minimally invasive robotic surgery and orthopedic services. With a network of more than 300 physicians, McLaren Oakland owns a network of employed physician offices throughout Oakland County and a nursing home in Lake Orion. McLaren Oakland is a verified trauma center and an accredited stroke center. To learn more, visit

About McLaren Health Care
McLaren Health Care Corporation, headquartered in Flint, MI, is a fully integrated health network, committed to quality, evidence-based patient care and cost efficiency. The McLaren system includes 12 hospitals, ambulatory surgery centers, imaging centers, the state’s only proton therapy center, an employed primary care physician network, commercial and Medicaid HMOs covering over 250,000 lives, home health care and hospice, durable medical equipment, retail pharmacy services, and a wholly-owned medical malpractice insurance company. McLaren operates the state’s largest network of cancer centers and providers anchored by Karmanos Cancer Institute - one of only two NCI-designated cancer centers in the state. McLaren has 22,000 employees and more than 37,500 individual providers in its state-wide provider network. Learn more at